Cargando…
A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain ch...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604010/ https://www.ncbi.nlm.nih.gov/pubmed/36288329 http://dx.doi.org/10.1371/journal.pone.0271425 |
_version_ | 1784817702954598400 |
---|---|
author | Marvel, Cherie L. Alm, Kylie H. Bhattacharya, Deeya Rebman, Alison W. Bakker, Arnold Morgan, Owen P. Creighton, Jason A. Kozero, Erica A. Venkatesan, Arun Nadkarni, Prianca A. Aucott, John N. |
author_facet | Marvel, Cherie L. Alm, Kylie H. Bhattacharya, Deeya Rebman, Alison W. Bakker, Arnold Morgan, Owen P. Creighton, Jason A. Kozero, Erica A. Venkatesan, Arun Nadkarni, Prianca A. Aucott, John N. |
author_sort | Marvel, Cherie L. |
collection | PubMed |
description | Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process. |
format | Online Article Text |
id | pubmed-9604010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-96040102022-10-27 A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease Marvel, Cherie L. Alm, Kylie H. Bhattacharya, Deeya Rebman, Alison W. Bakker, Arnold Morgan, Owen P. Creighton, Jason A. Kozero, Erica A. Venkatesan, Arun Nadkarni, Prianca A. Aucott, John N. PLoS One Research Article Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process. Public Library of Science 2022-10-26 /pmc/articles/PMC9604010/ /pubmed/36288329 http://dx.doi.org/10.1371/journal.pone.0271425 Text en © 2022 Marvel et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Marvel, Cherie L. Alm, Kylie H. Bhattacharya, Deeya Rebman, Alison W. Bakker, Arnold Morgan, Owen P. Creighton, Jason A. Kozero, Erica A. Venkatesan, Arun Nadkarni, Prianca A. Aucott, John N. A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease |
title | A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease |
title_full | A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease |
title_fullStr | A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease |
title_full_unstemmed | A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease |
title_short | A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease |
title_sort | multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment lyme disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604010/ https://www.ncbi.nlm.nih.gov/pubmed/36288329 http://dx.doi.org/10.1371/journal.pone.0271425 |
work_keys_str_mv | AT marvelcheriel amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT almkylieh amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT bhattacharyadeeya amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT rebmanalisonw amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT bakkerarnold amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT morganowenp amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT creightonjasona amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT kozeroericaa amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT venkatesanarun amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT nadkarnipriancaa amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT aucottjohnn amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT marvelcheriel multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT almkylieh multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT bhattacharyadeeya multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT rebmanalisonw multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT bakkerarnold multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT morganowenp multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT creightonjasona multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT kozeroericaa multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT venkatesanarun multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT nadkarnipriancaa multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease AT aucottjohnn multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease |